Physician profile

Brent A Parnell

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) · Birmingham, AL

NPI 1205957404

$208,466.19

in general payments reported to CMS, 2019-2025

40 companies · $41K in 2025

The $41K reported for 2025 was more than what 98% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$63,145.76
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$53,719.00
Travel and Lodging$12,652.23
Education$12,130.76
Food and Beverage$9,648.55
Honoraria$241.16

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $79,319.60 2019-2025 Solyx Sis System, Advantage System, General - Female Sui
Axonics, INC. $70,028.74 2020-2024 Axonics, Bulkamid
Caldera Medical, INC $30,799.53 2021-2024 Desara
Intuitive Surgical, INC. $16,876.95 2022-2025 Da Vinci Surgical System, Da Vinci Sp
Medtronic, INC. $2,359.16 2022-2025 Altaviva, Interstim
Allergan, INC. $2,208.01 2019-2021
Origami Surgical INC $2,000.00 2025 Stitchkit
Medtronic USA, INC. $1,364.49 2019
Abbvie INC. $704.86 2019-2025
Astellas Pharma US INC $473.18 2019-2025 Veozah, Myrbetriq
Bluewind Medical $332.36 2024 Revi
Sumitomo Pharma America, INC. $296.45 2023-2025 Myfembree, Gemtesa
Pfizer INC. $265.66 2019-2023
Therapeuticsmd, INC. $155.71 2019-2022
Duchesnay USA Incorporated $144.18 2019
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Myovant Sciences INC. $133.02 2021-2022
Hologic Sales and Service, LLC $112.48 2019-2024 Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure
Coopersurgical, INC. $85.98 2020-2025 Paragard T 380a, Ally II Ups
Urovant Sciences INC $82.83 2022
Channel Medsystems, INC. $73.49 2022
Bayer Healthcare Pharmaceuticals INC. $69.13 2023-2025
Mayne Pharma Commercial LLC $62.00 2023-2025
Conmed Corporation $61.77 2020-2024 Airseal, Vcare, Visiclear
Coloplast Corp $61.29 2019-2024
Shield Therapeutics INC $56.12 2024-2025
Amgen INC. $47.85 2019-2021
Kerecis Limited $32.91 2025 Kerecis Surgiclose, Kerecis Graftguide
Amag Pharmaceuticals, INC. $30.05 2019
Exeltis, USA INC. $28.55 2021-2024 Slynd
Minerva Surgical, INC $27.51 2020-2023
Merck Sharp & Dohme LLC $26.44 2020-2021
Mylan Pharmaceuticals INC. $24.00 2019-2022
Roche Diagnostics Corporation $20.06 2020
Exact Sciences Corporation $18.01 2025 Cologuard Collection Kit
Sage Therapeutics, LLC $17.85 2025 Zurzuvae
Evofem Biosciences, INC. $14.81 2021
Si-Bone, INC. $13.79 2021
Davol INC. $13.75 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $11.84 2020
Covidien Lp $11.78 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brent A Parnell

$208,466.19

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $41K reported for 2025 was more than what 98% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).

https://glasscript.com/doctor/281850/brent-a-parnell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.